(Q36617277)

English

Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma

scientific article published on January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma (English)

1 reference

Europe PubMed Central

15 August 2017

author name string

Imamura H

1

1 reference

Europe PubMed Central

15 August 2017

Haga S

2

1 reference

Europe PubMed Central

15 August 2017

Shimizu T

3

1 reference

Europe PubMed Central

15 August 2017

Watanabe O

4

1 reference

Europe PubMed Central

15 August 2017

Kajiwara T

5

1 reference

Europe PubMed Central

15 August 2017

Aiba M

6

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

79

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

172-178

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690029

0 references

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Ductal carcinoma in situ: a proposal for a new classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Thymidine labeling index and Ki-67 growth fraction in lesions of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Review: assessment of cell proliferation in histological material

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Measuring cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

30 September 2017

Standardized mitotic counts in breast cancer. Evaluation of the method.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

28 June 2018

The impact of tumor size and histology on local control after breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

28 June 2018

Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

28 June 2018

MIB1-determined proliferative activity in intraductal components and prognosis of invasive ductal breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

20 September 2018

Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

20 September 2018

Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

20 September 2018

Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362174

20 September 2018

The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell kinetics of histologic variants of in situ breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleolar organizer regions relate to growth fractions in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of morphologic and immunocytochemical assessments of cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10408711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus, antibodies, and infectivity. Paradox, pragmatism, and policy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690029

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6690029

1 reference

Europe PubMed Central

15 August 2017

release_swb4r5w6yrdp5bl7ms4k77no3y

1 reference

https://api.fatcat.wiki/v0/release/swb4r5w6yrdp5bl7ms4k77no3y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36617277&oldid=1835495591"